Health
Researchers identify anti-inflammatory prodrug Minnelide with potential against SARS-CoV-2 – News-Medical.Net
Using a transgenic mouse model of COVID-19, they have observed that treatment with Minnelide reduces viral load and inflammation in the lungs and improves survival….
A team of scientists from the United States has recently investigated the efficacy of an anti-inflammatory prodrug Minnelide in treating coronavirus disease 2019 (COVID-19), a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Using a transgenic mouse model of COVID-19, they have observed that treatment with Minnelide reduces viral load and inflammation in the lungs and improves survival. The study is currently available on the bioRxiv* preprint server.
Background
As…
-
Business23 hours agoWhy it’s time to buy Domino’s, Flight Centre, and WiseTech shares
-
Business22 hours agoHow to build a million-dollar ASX share portfolio in 25 years
-
General21 hours agoLabor’s socialist bedroom tax | The Spectator Australia
-
Noosa News17 hours agoHow cutting diplomatic ties with Tehran has affected Iranian community in Australia